Web3 apr. 2024 · Press Releases. PR Newswire. Henlius 2024 Annual Results: Significant Achievements in Commercialisation, Surged to RMB3.2 Billion in Revenues. Henlius … Web22 mrt. 2024 · Henlius has administered the first dose in its international Phase III trial into its denosumab biosimilar candidate, HLX14. The firm has also revealed that its new …
Organon Enters into Global License Agreement to Commercialize …
Web13 apr. 2024 · Press Release 04/04/2024 Rhenus and TSR set up a joint venture for reusing and recycling lithium-ion… Press contact Rhenus SE & Co. KG Rhenus-Platz 1 … Web1 uur geleden · The global HER2 Positive Gastric Cancer Market is currently valued at US$ 1261.8 million in 2024, with a CAGR of 3.5% expected. Because of technological advancements in healthcare, the market is expected to reach US$1779.8 million by 2033. “Increased disease burden and pipeline candidate approval are likely to drive the growth … harriet carter catalog by mail
Henlius Novel Anti PD-L1/TIGIT Bispecific Antibody Received
Web20 apr. 2024 · The National Medical Products Administration (NMPA) of China has accepted Shanghai Henlius Biotech’s New Drug Application (NDA) for Hansizhuang (serplulimab) for use in combination with chemotherapy for the first-line treatment of extensive stage small cell lung cancer (ES-SCLC). Web3 apr. 2024 · 2024-04-03 00:16 HKT On August 18, 2024, Henlius announced its first half results. Compared with the time when the company first proposed the concept of evolution from Biotech to Biopharma, the … Web12 apr. 2024 · Select newer press release: ... Utlicensierade program inkluderar AC101/HLX22, i fas 2-utveckling, till Shanghai Henlius Biotech Inc. och en ej offentliggjord målmolekyl till Biotheus Inc. Alligator Biosciences aktier handlas på Nasdaq Stockholm under tickern ”ATORX”. harriet carter free shipping code